Professor, Medicine, Indiana University School of Medicine
Gastroenterology
Dr. Rakesh Vinayek, MD
Rakesh Vinayek practices Gastroenterology. Rakesh Vinayek, MD is a published doctor as well. He has 35 publications published. The latest was: Disseminated histoplasmosis in a patient after orthotopic liver transplantation. He is registered with Medicare and accepts Medicare payments.
Publications
- Efficacy of Combined Jejunal and Colonic Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
- The therapeutic approaches for hepatitis C virus: protease inhibitors and polymerase inhibitors.
- The next step for taribavirin.
- Disseminated histoplasmosis in a patient after orthotopic liver transplantation.
- A newly recognized action of cholecystokinin on pancreatic acini-release of lactate dehydrogenase.
- Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison Syndrome.
- Characterization of insulin-like growth factor I receptors in human Esophageal epithelial cells.
- Occupation of low-affinity cholecystokinin (CCK) receptors by CCK activates signal transduction and stimulates amylase secretion in pancreatic acinar cells.
- Inhibition of the antisecretory effects of [D-Ala2,D-Leu5]enkephalin in the guinea-pig ileum by a selective delta opioid antagonist.
- Role of selective angiography in the management of patients with Zollinger-Ellison Syndrome.
- Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison Syndrome.
- Medical management of patients with Zollinger-Ellison Syndrome who have had previous gastric surgery: a prospective study.
- Tolerance and cross-tolerance to the antisecretory effects of enkephalins on the guinea-pig ileal mucosa.
- Prospective study of chemotherapy in patients with metastatic gastrinoma.
- Famotidine: effective treatment of Zollinger-Ellison Syndrome.
- Famotidine in the therapy of Gastric hypersecretory states.
- Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison Syndrome: a prospective study.
- Gastrinomas: comparison of MR imaging with CT, angiography, and US.
- Secretin and calcium provocative tests in the Zollinger-Ellison Syndrome. A prospective study.
- Carbachol-induced down-regulation of high-affinity receptors for vasoactive Intestinal peptide.
- Regulation of bombesin receptors on pancreatic acini by cholecystokinin.
- Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
- Detection of Duodenal gastrinomas by operative endoscopic transillumination. A prospective study.
- Zollinger-Ellison Syndrome. Recent advances in the management of the gastrinoma.
- Carbachol-induced down-regulation of receptors for pancreatic secretagogues.
- Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison Syndrome.
- Down-regulation and recycling of high affinity cholecystokinin receptors on pancreatic acinar cells.
- Zollinger-Ellison syndrome: prospective assessment of Abdominal US in the localization of gastrinomas.
- Intravenous omeprazole in patients with Zollinger-Ellison Syndrome undergoing surgery.
- Reflux Esophagitis in patients with Zollinger-Ellison syndrome.
- Bombesin receptor antagonists. 2. Analogues based on substance P antagonists.
- Receptor identification.
- Carbachol desensitizes pancreatic enzyme secretion by downregulation of receptors.
- Carbachol does not down-regulate substance P receptors in pancreatic acini.
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Fecal Impaction Removal
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Education
-
University of Chicago -
UMDNJ-University Hospital -
Mount Sinai Medical Center of Florida -
All India Institute of Medical Sciences
Drug Facts
| NPI NUMBER | 1457382210 | |
| NPPES Provider LastName | VINAYEK | |
| NPPES Provider FirstName | RAKESH | |
| NPPES Provider ZIPCode | 462025149 | |
| NPPES Provider State | IN | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 486.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457382210 |
| Last Name Of The Provider | VINAYEK |
| First Name Of The Provider | RAKESH |
| View All |
Similar Doctors
|
Dr. Debra J. Helper, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Morelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David C. Pound, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles J. Kahi, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David L. Bash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William C. Erdel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sweta R. Tandra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christen M. Klochan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wesley C. Leung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hak N. Kim, MD |